Search results
Showing 901 to 915 of 1561 results for do not do recommendations
Recommendation ID IPG737/01 Question Evidence on the safety and efficacy of prostatic urethral temporary implant insertion for lower...
Recommendation ID IPG739/01 Question Evidence on the efficacy and safety of neurostimulation of lumbar muscles for refractory...
Recommendation ID NG64/3 Question Effectiveness and cost effectiveness of drug misuse prevention interventions for groups vulnerable to
Recommendation ID NG31/1 Question Recognising dying:- What can multiprofessional teams do to reduce the impact of...
Recommendation ID NG150/1 Question What is the effectiveness, cost effectiveness and acceptability of the whole family approach to...
Apremilast for treating moderate to severe plaque psoriasis (TA419)
Evidence-based recommendations on apremilast (Otezla) for treating moderate to severe plaque psoriasis in adults.
Our science policy and research programme team produces high-quality, impactful research.
Recommendation ID PH47/1 Question Recommendation 1 Research studies and trials. Who should take action? Research councils,...
Recommendation ID PH47/4 Question Recommendation 4 Weight management programmes. Who should take action? Research councils,...
Evidence-based recommendations on pembrolizumab (Keytruda) for relapsed or refractory classical Hodgkin lymphoma in people 3 years and over.
Esketamine nasal spray for treatment-resistant depression (TA854)
Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.
Evidence-based recommendations on midcarpal hemiarthroplasty for wrist arthritis in adults. This involves using a metal implant to create an artificial wrist joint, to relieve pain and maintain movement.
View recommendations for HTG529Show all sections
Evidence-based recommendations on molnupiravir (Lagevrio) for treating mild to moderate COVID-19 in adults who have a positive SARS-CoV-2 test.
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency (HST26)
Evidence-based recommendations on eladocagene exuparvovec (Upstaza) for treating aromatic L-amino acid decarboxylase deficiency in people 18 months and over.
Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation (HTG752)
Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve.
View recommendations for HTG752Show all sections